Merck to Acquire Maryland-based OncoImmune’s Promising COVID-19 Drug in $425 Million Deal
Merck to Acquire Maryland-based OncoImmune’s Promising COVID-19 Drug in $425 Million Deal

Merck to Acquire Maryland-based OncoImmune’s Promising COVID-19 Drug in $425 Million Deal
JHU Spinout Thrive Earlier Detection Lands up to $2.15 Billion in Acquisition by Exact Sciences
UMB Startup Breethe Acquired by Abiomed to Commercialize Wearable Artificial Lung System The Deal Marks Another Successful Exit Supported by UM Ventures May 26, 2020 Breethe, a company built on [….]
The BioBuzz on… Harpoon Medical’s CEO Bill Niland via original post on 4.4.2014 Given Harpoon Medical’s success and recent acquisition by Edwards Life Sciences we wanted to bring back this [….]
Unknown Future for Frederick Vaccine Company After Recent Acquisition by General Dynamics General Dynamics acquires CSRA for $9.6 Billion Among the giant Federal Government defense contractors that line the DC beltway there is a [….]
Biotech Mergers & Acquisitions Were Red Hot In Maryland This Summer – 2013 It was a red hot summer in the board rooms for many of Maryland biotech companies. The [….]